These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16866262)

  • 1. [The part of the hormone-cyclase system in achieving the therapeutic effect of hydrochloric acid secretion inhibitors at the duodenal ulcer].
    Vahrushev IaM; Muravtseva OV
    Eksp Klin Gastroenterol; 2006; (2):31-5, 126. PubMed ID: 16866262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complex evaluation of the action of inhibitors of hydrochloric acid secretion on gastric function in ulcer disease].
    Vakhrushev IaM; Muravtseva OV
    Ter Arkh; 2006; 78(2):35-8. PubMed ID: 16613094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acid and gastrin secretion before and after treatment with pirenzepine in patients with duodenal ulcer].
    Sternini C; Tomassetti P; Bonora G; Ferri GL; Botti PL; Vezzadini P
    Minerva Dietol Gastroenterol; 1982; 28(1):59-64. PubMed ID: 6896230
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
    Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients.
    Dal Santo PL; Vianello F; Germana B; Dotto P; Laino G; Del Bianco T; Plebani M; Leandro G; Savarino V; Di Mario F
    Z Gastroenterol; 1993 Jan; 31(1):11-4. PubMed ID: 8447149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of inhibitors of gastric secretion on the acid-proteolytic activity of the stomach in ulcer disease].
    Gorshkov VA; Nasonova NV
    Klin Med (Mosk); 1988 Apr; 66(4):58-62. PubMed ID: 3294498
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastric antiulcer activity of pentacaine: possible mechanism of action.
    Nosál'ová V; Babul'ová A
    Physiol Res; 1994; 43(3):181-6. PubMed ID: 7993886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
    Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sucralfate and alsucral in the treatment of uncomplicated duodenal ulcer].
    Cherniakevich SA; Borisova EO; Babkova IV
    Sov Med; 1991; (3):71-2. PubMed ID: 1882301
    [No Abstract]   [Full Text] [Related]  

  • 10. [The hormone-cyclase system and its possible role in disorders of the absorptive function of the intestines].
    Vakhrushev IaM
    Vestn Akad Med Nauk SSSR; 1989; (3):61-6. PubMed ID: 2728583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience with the treatment of duodenal ulcer using H2-histamine receptor blockers].
    Smagin VG; Minushkin ON; Buglakov SA; Bogdanov AN; Murashko VV
    Ter Arkh; 1986; 58(2):25-30. PubMed ID: 3518121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ulcer therapy without acid inhibition].
    Koelz HR
    Schweiz Med Wochenschr; 1984 May; 114(20):686-93. PubMed ID: 6547542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of duodenal peptic ulcer (author's transl)].
    Ugarte G
    Rev Med Chil; 1981 Apr; 109(4):346-8. PubMed ID: 7323521
    [No Abstract]   [Full Text] [Related]  

  • 14. Acid secretion, response to omeprazole, and Helicobacter pylori status.
    Treiber G; Klotz U
    Am J Gastroenterol; 1997 Apr; 92(4):555-6. PubMed ID: 9128298
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the synthetic PGE1 derivative misoprostol on basal, stimulated and nocturnal acid secretion in duodenal ulcer cases. Mechanism of action.
    Buzás G; Puscas I; Persa F; Reznicek A
    Acta Physiol Hung; 1989; 73(2-3):185-91. PubMed ID: 2512765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
    Bulgakov SA
    Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastric acid secretion and the changes of blood gastrin, glucose and insulin levels following 2-deoxy-D-glucose administration in hypersecretory and normosecretory duodenal ulcer patients.
    Popiela T; Szafran H; Szafran Z; Sztefko K; Opławski B
    Acta Physiol Pol; 1982; 33(5-6):587-95. PubMed ID: 6764708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of calcium channel inhibitors on acid gastric secretion in ulcer patients.
    Banciu T; Kozicek C
    Med Interne; 1986; 24(3):235-8. PubMed ID: 3775216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of duodenal ulcer with carbonic anhydrase inhibitors in combination with adrenergic beta blockaders].
    Puşcas I; Reznicek A; Buzaş G; Milaş D; Kovacs E; Sturzu D; Perşa F; Nemeş-Brateş R; Vălean S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(6):541-4. PubMed ID: 2871612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.